In vitro models for the study of non-alcoholic fatty liver disease

Current Medicinal Chemistry

Volumn 18, Issue 7, 2011, Pages 1079-1084

  Chavez Tapia, N C ^a,c   Rosso, N ^a   Tiribelli, C ^a,b  

^a Centro Studi Fegato   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c LIVER RESEARCH UNIT   (Mexico)

Author keywords

Biological models; Biomedical research; Fatty acids; Fatty liver

Indexed keywords

FATTY ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL IMMORTALIZATION; CHRONIC LIVER DISEASE; DISEASE MODEL; END STAGE LIVER DISEASE; HUMAN; IN VITRO STUDY; INFLAMMATION; LIPID METABOLISM; LIVER CELL; LIVER FIBROSIS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; STELLATE CELL;

ANIMALS; CELL LINE; DIETARY FATS; FATTY LIVER;

EID: 79952776936     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711794940842     Document Type: Article

References (64)

1. Bugianesi, E.; Bellentani, S.; Bedogni, G.; Tiribelli, C. Clinical update on non-alcoholic fatty liver disease and steatohepatitis. Ann. Hepatol., 2008, 7(2), 157-160. (Pubitemid 351845528)
2. Chavez-Tapia, N.C.; Sanchez-Avila, F.; Vasquez-Fernandez, F.; Torres- Machorro, A.; Tellez-Avila, F.I.; Uribe, M. Non-alcoholic fatty-liver disease in pediatric populations. J. Pediatr. Endocrinol. Metab., 2007, 20(10), 1059-1073. (Pubitemid 350148455)
3. Guerrero, R.; Vega, G.L.; Grundy, S.M.; Browning, J.D. Ethnic differences in hepatic steatosis: An insulin resistance paradox? Hepatology (Baltimore, Md., 2009, 49(3), 791-801.
4. Tarantino, G.; Saldalamacchia, G.; Conca, P.; Arena, A. Non-alcoholic fatty liver disease: Further expression of the metabolic syndrome. J. Gastroenterol. Hepatol., 2007, 22(3), 293-303. (Pubitemid 46238755)
5. Chavez-Tapia, N.N.; Uribe, M.; Ponciano-Rodriguez, G.; Medina-Santillan, R.; Mendez-Sanchez, N. New insights into the pathophysiology of nonalcoholic fatty liver disease. Ann. Hepatol., 2009, 8(Suppl 1), S9-17.
6. Nobili, V.; Alisi, A.; Raponi, M. Pediatric non-alcoholic fatty liver disease: Preventive and therapeutic value of lifestyle intervention. World J. Gastroenterol., 2009, 15(48), 6017-6022.
7. Rafiq, N.; Younossi, Z.M. Effects of weight loss on nonalcoholic fatty liver disease. Semin. Liver Dis., 2008, 28(4), 427-433.
8. Larter, C.Z.; Yeh, M.M. Animal models of NASH: Getting both pathology and metabolic context right. J. Gastroenterol. Hepatol., 2008, 23(11), 1635-1648.
9. Gomez-Lechon, M.J.; Donato, M.T.; Castell, J.V.; Jover, R. Human hepatocytes in primary culture: The choice to investigate drug metabolism in man. Curr. Drug Metab., 2004, 5(5), 443-462. (Pubitemid 39276606)
10. Donato, M.T.; Lahoz, A.; Castell, J.V.; Gomez-Lechon, M.J. Cell lines: A tool for in. vitro drug metabolism studies. Curr. Drug Metab., 2008, 9(1), 1-11 (Pubitemid 351201665)
11. Wursthorn, K.; Manns, M.P.; Wedemeyer, H. Natural history: The importance of viral load, liver damage and HCC. Best Pract. Res. Clin. Gastroentrol., 2008, 22(6), 1063-1079.
12. Dambach, D.M.; Andrews, B.A.; Moulin, F. New technologies and screening strategies for hepatotoxicity: Use of in vitro models. Toxicol. Pathol., 2005, 33(1), 17-26. (Pubitemid 40216800)
13. Smedsrod, B.; Le Couteur, D.; Ikejima, K.; Jaeschke, H.; Kawada, N.; Naito, M.; Knolle, P.; Nagy, L.; Senoo, H.; Vidal-Vanaclocha, F.; Yamaguchi, N. Hepatic sinusoidal cells in health and disease: Update from the 14th International Symposium. Liver Int., 2009, 29(4), 490-501.
14. Peng, Y.; Murr, M.M. Establishment of immortalized rat Kupffer cell lines. Cytokine, 2007, 37(3), 185-191. (Pubitemid 46880387)
15. Krause, P.; Saghatolislam, F.; Koenig, S.; Unthan-Fechner, K.; Probst, I. Maintaining hepatocyte differentiation in. vitro through co-culture with hepatic stellate cells. In Vitro Cell. Dev. Biol., 2009, 45(5-6), 205-212.
16. Thomas, R.J.; Bhandari, R.; Barrett, D.A.; Bennett, A.J.; Fry, J.R.; Powe, D.; Thomson, B.J.; Shakesheff, K.M. The effect of three-dimensional co-culture of hepatocytes and hepatic stellate cells on key hepatocyte functions in vitro. Cells Tissues Org., 2005, 181(2), 67-79.
17. van de Bovenkamp, M.; Groothuis, G.M.; Draaisma, A.L.; Merema, M.T.; Bezuijen, J.I.; van Gils, M.J.; Meijer, D.K.; Friedman, S.L.; Olinga, P. Precision- cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieu. Toxicol. Sci., 2005, 85(1), 632-638. (Pubitemid 40614292)
18. van de Bovenkamp, M.; Groothuis, G.M.; Meijer, D.K.; Slooff, M.J.; Olinga, P. Human liver slices as an in vitro model to study toxicity-induced hepatic stellate cell activation in a multicellular milieu. Chemico-Biol. Interact., 2006, 162(1), 62-69. (Pubitemid 44080167)
19. Breen, K.J.; Schenker, S.; Heimberg, M. Fatty liver induced by tetracycline in the rat. Dose-response relationships and effect of sex. Gastroenterology, 1975, 69(3), 714-723.
20. Deboyser, D.; Goethals, F.; Krack, G.; Roberfroid, M. Investigation into the mechanism of tetracycline-induced steatosis: Study in isolated hepatocytes. Toxicol. Appl. Pharmacol., 1989, 97(3), 473-479. (Pubitemid 19094963)
21. Amacher, D.E.; Martin, B.A. Tetracycline-induced steatosis in primary canine hepatocyte cultures. Fundam. Appl. Toxicol., 1997, 40(2), 256-263.
22. Bugianesi, E.; McCullough, A.J.; Marchesini, G. Insulin resistance: A metabolic pathway to chronic liver disease. Hepatology, 2005, 42(5), 987-1000. (Pubitemid 43112663)
23. Tilg, H.; Hotamisligil, G.S. Nonalcoholic fatty liver disease: Cytokineadipokine interplay and regulation of insulin resistance. Gastroenterology, 2006, 131(3), 934-945. (Pubitemid 44307061)
24. Iwasaki, Y.; Kambayashi, M.; Asai, M.; Yoshida, M.; Nigawara, T.; Hashimoto, K. High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro. J. Diabetes Complicat., 2007, 21(1), 56-62. (Pubitemid 44960844)
25. Jensen, M.D. Role of body fat distribution and the metabolic complications of obesity. J. Clin. Endocrinol. Metab., 2008, 93(11 Suppl 1), S57-63.
26. Bassols, J.; Ortega, F.J.; Moreno-Navarrete, J.M.; Peral, B.; Ricart, W.; Fernandez-Real, J.M. Study of the proinflammatory role of human differentiated omental adipocytes. J. Cell. Biochem., 2009.
27. Starr, M.E.; Evers, B.M.; Saito, H. Age-associated increase in cytokine production during systemic inflammation: Adipose tissue as a major source of IL-6. J. Gerontol., 2009, 64(7), 723-730.
28. Nunez, N.P.; Hursting, S.D.; Yakar, S.; Fowler, D.; Vinson, C. Obesity provides a permissive milieu in inflammation-associated carcinogenesis: Analysis of insulin and IGF pathways. Methods Mol. Biol. (Clifton, N.J.), 2009, 512, 29-37.
29. Dyck, D.J. Adipokines as regulators of muscle metabolism and insulin sensitivity. Appl. Physiol. Nutr. Metab., 2009, 34(3), 396-402.
30. Wang, Z.; Lv, J.; Zhang, R.; Zhu, Y.; Zhu, D.; Sun, Y.; Zhu, J.; Han, X. Coculture with fat cells induces cellular insulin resistance in primary hepatocytes. Biochem. Biophys. Res. Commun., 2006, 345(3), 976-983. (Pubitemid 43776513)
31. Girard, J.; Lafontan, M. Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: Visceral adipose tissue production and liver metabolism. Diabetes Metab., 2008, 34(5), 439-445.
32. Srivastava, S.; Chan, C. Application of metabolic flux analysis to identify the mechanisms of free fatty acid toxicity to human hepatoma cell line. Biotechnol. Bioeng., 2008, 99(2), 399-410. (Pubitemid 351158288)
33. Tirosh, O.; Ilan, E.; Anavi, S.; Ramadori, G.; Madar, Z. Nutritional lipidinduced oxidative stress leads to mitochondrial dysfunction followed by necrotic death in FaO hepatocytes. Nutrition (Burbank, Los Angeles County, Calif), 2009, 25(2), 200-208.
34. Shimabukuro, M.; Zhou, Y.T.; Levi, M.; Unger, R.H. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes. Proc. Natl. Acad. Sci. U.S.A., 1998, 95(5), 2498-2502. (Pubitemid 28145970)
35. Malhi, H.; Bronk, S.F.; Werneburg, N.W.; Gores, G.J. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J. Biol. Chem., 2006, 281(17), 12093-12101. (Pubitemid 43855473)
36. Day, C.P.; James, O.F. Steatohepatitis: A tale of two "hits"? Gastroenterology, 1998, 114(4), 842-845.
37. Pusl, T.; Wild, N.; Vennegeerts, T.; Wimmer, R.; Goke, B.; Brand, S.; Rust, C. Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis. Biochem. Biophys. Res. Commun., 2008, 371(3), 441-445.
38. Joshi-Barve, S.; Barve, S.S.; Amancherla, K.; Gobejishvili, L.; Hill, D.; Cave, M.; Hote, P.; McClain, C.J. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology (Baltimore, Md.), 2007, 46(3), 823-830. (Pubitemid 47436129)
39. Janorkar, A.V.; King, K.R.; Megeed, Z.; Yarmush, M.L. Development of an in vitro cell culture model of hepatic steatosis using hepatocyte-derived reporter cells. Biotechnol. Bioeng., 2009, 102(5), 1466-1474.
40. Chavez-Tapia, N.; Rosso, N.; Tiribelli, C. Increased expression of IL-6 and IL-8 mrna in human immortalized hepatocytes after fat overload. J. Hepatol., 2009, 698.
41. Gentile, C.L.; Pagliassotti, M.J. The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. J. Nutr. Biochem., 2008, 19(9), 567-576.
42. Abergel, A.; Sapin, V.; Dif, N.; Chassard, C.; Darcha, C.; Marcand-Sauvant, J.; Gaillard-Martinie, B.; Rock, E.; Dechelotte, P.; Sauvant, P. Growth arrest and decrease of alpha-SMA and type I collagen expression by palmitic acid in the rat hepatic stellate cell line PAV-1. Dig. Dis. Sci., 2006, 51(5), 986-995. (Pubitemid 44030827)
43. Bechmann, L.P.; Zahn, D.; Gieseler, R.K.; Fingas, C.D.; Marquitan, G.; Jochum, C.; Gerken, G.; Friedman, S.L.; Canbay, A. Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells. Hepatol. Res., 2009, 39(6), 601-608.
44. Hanhoff, T.; Lucke, C.; Spener, F. Insights into binding of fatty acids by fatty acid binding proteins. Mol. Cell. Biochem., 2002, 239(1-2), 45-54. (Pubitemid 35385794)
45. Tso, P.; Nauli, A.; Lo, C.M. Enterocyte fatty acid uptake and intestinal fatty acid-binding protein. Biochem. Soc. Trans., 2004, 32(Pt 1), 75-78. (Pubitemid 38283017)
46. Richieri, G.V.; Anel, A.; Kleinfeld, A.M. Interactions of long-chain fatty acids and albumin: Determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry, 1993, 32(29), 7574-7580. (Pubitemid 23232334)
47. Leclercq, I.; Horsmans, Y.; Desager, J.P.; Delzenne, N.; Geubel, A.P. Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation. J. Hepatol., 1998, 28(3), 410-416. (Pubitemid 28133544)
48. Chalasani, N.; Gorski, J.C.; Asghar, M.S.; Asghar, A.; Foresman, B.; Hall, S.D.; Crabb, D.W. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology, 2003, 37(3), 544-550. (Pubitemid 36258775)
49. Weltman, M.D.; Farrell, G.C.; Hall, P.; Ingelman-Sundberg, M.; Liddle, C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology, 1998, 27(1), 128-133. (Pubitemid 28041545)
50. Van Remmen, H.; Williams, M.D.; Heydari, A.R.; Takahashi, R.; Chung, H.Y.; Yu, B.P.; Richardson, A. Expression of genes coding for antioxidant enzymes and heat shock proteins is altered in primary cultures of rat hepatocytes. J. Cell. Physiol., 1996, 166(2), 453-460. (Pubitemid 26042423)
51. Rodriguez-Antona, C.; Donato, M.T.; Boobis, A.; Edwards, R.J.; Watts, P.S.; Castell, J.V.; Gomez-Lechon, M.J. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: Molecular mechanisms that determine lower expression in cultured cells. Xenobiotica, 2002, 32(6), 505-520. (Pubitemid 34743622)
52. Wobser, H.; Dorn, C.; Weiss, T.S.; Amann, T.; Bollheimer, C.; Buttner, R.; Scholmerich, J.; Hellerbrand, C. Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells. Cell Res., 2009, 19(8), 996-1005.
53. Fujimoto, Y.; Itabe, H.; Kinoshita, T.; Homma, K.J.; Onoduka, J.; Mori, M.; Yamaguchi, S.; Makita, M.; Higashi, Y.; Yamashita, A.; Takano, T. Involvement of ACSL in local synthesis of neutral lipids in cytoplasmic lipid droplets in human hepatocyte HuH7. J. Lipid. Res., 2007, 48(6), 1280-1292. (Pubitemid 47312030)
54. Akazawa, Y.; Cazanave, S.; Mott, J.L.; Elmi, N.; Bronk, S.F.; Kohno, S.; Charlton, M.R.; Gores, G.J. Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis. J. Hepatol., 52(4), 586-593.
55. Kim, K.S.; Oh da, H.; Choi, H.M.; Bang, J.S.; Ryu, C.J.; Kim, J.H.; Yoo, M.C.; Yang, H.I. Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes. Eur. J. Pharmacol., 2009, 613(1-3), 167-175.
56. Zhou, L.; Sell, H.; Eckardt, K.; Yang, Z.; Eckel, J. Conditioned medium obtained from in. vitro differentiated adipocytes and resistin induce insulin resistance in human hepatocytes. FEBS Lett., 2007, 581(22), 4303-4308. (Pubitemid 47301863)
57. Guo, W.; Huang, N.; Cai, J.; Xie, W.; Hamilton, J.A. Fatty acid transport and metabolism in HepG2 cells. Am. J. Physiol. Gastrointest. Liver Physiol., 2006, 290(3), G528-534.
58. Ha, J.S.; Theriault, A.; Bhagavan, N.V.; Ha, C.E. Fatty acids bound to human serum albumin and its structural variants modulate apolipoprotein B secretion in HepG2 cells. Biochim. Biophys. Acta, 2006, 1761(7), 717-724. (Pubitemid 44108752)
59. Gomez-Lechon, M.J.; Donato, M.T.; Martinez-Romero, A.; Jimenez, N.; Castell, J.V.; O'Connor, J.E. A human hepatocellular in. vitro model to investigate steatosis. Chem. Biol. Interact., 2007, 165(2), 106-116. (Pubitemid 46072796)
60. Reed, R.G.; Feldhoff, R.C.; Clute, O.L.; Peters, T., Jr. Fragments of bovine serum albumin produced by limited proteolysis. Conformation and ligand binding. Biochemistry, 1975, 14(21), 4578-4583.
61. Wei, Y.; Wang, D.; Topczewski, F.; Pagliassotti, M.J. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am. J. Physiol. Endocrinol. Metab., 2006, 291(2), E275- 281. (Pubitemid 44035286)
62. Nakamura, S.; Takamura, T.; Matsuzawa-Nagata, N.; Takayama, H.; Misu, H.; Noda, H.; Nabemoto, S.; Kurita, S.; Ota, T.; Ando, H.; Miyamoto, K.; Kaneko, S. Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J. Biol. Chem., 2009, 284(22), 14809-14818.
63. De Gottardi, A.; Vinciguerra, M.; Sgroi, A.; Moukil, M.; Ravier- Dall'Antonia, F.; Pazienza, V.; Pugnale, P.; Foti, M.; Hadengue, A. Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes. Lab. Invest., 2007, 87(8), 792-806. (Pubitemid 47077255)
64. Nieto, N. Ethanol and fish oil induce NFkappaB transactivation of the collagen alpha2(I) promoter through lipid peroxidation-driven activation of the PKC-PI3K-Akt pathway. Hepatology, 2007, 45(6), 1433-1445. (Pubitemid 46918327)